# MGRX (Mangoceuticals, Inc.) - SEC EDGAR Financial Statements

> Mangoceuticals, Inc. reported $300K in revenue and a net loss of $11.04M for the trailing twelve months ended September 30, 2026 (down 17.5% year over year), with a 52.9% gross margin and a -2887.5% operating margin.

- Canonical: https://convexityos.com/fundamentals/MGRX
- Markdown: https://convexityos.com/fundamentals/MGRX.md
- SEC CIK: 0001938046
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:10 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001938046&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $300K | -17.5% YoY |
| Operating Income | TTM | -$8.68M | -2887.5% margin |
| Net Income | TTM | -$11.04M | -3673.7% net margin |
| Diluted EPS | TTM | -$0.54 | Split-adjusted |
| Free Cash Flow | TTM | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $659K | Total debt: $266K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| **Revenue** | $456K | $616K | $731K | $8.9K |
| Cost of Revenue | $54K | $93K | $155K | $4.1K |
| **Gross Profit** | $250K | $380K | $432K | $4.8K |
| Total Operating Expenses | $18.28M | $8.35M | $9.65M | $2.00M |
| **Operating Income** | -$18.03M | -$7.97M | -$9.22M | -$1.99M |
| **EBITDA** | -$16.91M | -$7.96M | -$9.19M | -$1.99M |
| Interest Expense | $104K | $14K | -$6.5K | $6.5K |
| Income Before Tax | -$20.64M | -$8.71M | -$9.21M | -$2.00M |
| **Net Income** | -$20.64M | -$8.71M | -$9.21M | -$2.00M |
| Basic EPS | -$2.17 | -$4.80 | -$8.58 | -$2.85 |
| **Diluted EPS** | -$2.17 | -$4.80 | -$8.58 | -$2.85 |
| Basic Shares Outstanding | 10.1M | 2.0M | 1.1M | 719.9K |
| Diluted Shares Outstanding | 10.1M | 2.0M | 1.1M | 719.9K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $70K | $69K | $68K | $94K | $84K | $168K | $109K | $105K |
| Cost of Revenue | $8.8K | $10K | $8.2K | $8.5K | $2.4K | $19K | $25K | $21K |
| **Gross Profit** | $38K | $44K | $29K | $47K | $51K | $90K | $62K | $80K |
| Total Operating Expenses | $3.35M | $1.08M | $3.16M | $1.25M | $7.31M | $5.36M | $4.64M | $1.76M |
| **Operating Income** | -$3.31M | -$1.03M | -$3.13M | -$1.21M | -$7.26M | -$5.27M | -$4.58M | -$1.68M |
| **EBITDA** | -$3.03M | -$753K | -$2.85M | -$924K | -$7.26M | -$5.27M | -$4.58M | -$1.68M |
| Interest Expense | $1.1K | -- | -- | $20K | $76K | $22K | -$14K | -- |
| Income Before Tax | -$3.55M | -$1.31M | -$3.40M | -$2.77M | -$7.62M | -$5.42M | -$4.84M | -$1.95M |
| **Net Income** | -$3.55M | -$1.31M | -$3.40M | -$2.77M | -$7.62M | -$5.42M | -$4.84M | -$1.95M |
| Basic EPS | -$0.19 | -$0.09 | -$0.22 | -- | -$0.69 | -$0.57 | -$1.12 | -- |
| **Diluted EPS** | -$0.19 | -$0.09 | -$0.22 | -- | -$0.69 | -$0.57 | -$1.12 | -- |
| Basic Shares Outstanding | 20.4M | 17.1M | 16.5M | -- | 11.5M | 10.0M | 4.6M | -- |
| Diluted Shares Outstanding | 20.4M | 17.1M | 16.5M | -- | 11.5M | 10.0M | 4.6M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $1.49M | $59K | $739K | $683K |
| **Cash & Short-Term Investments** | $1.49M | $59K | $739K | $683K |
| Inventory | -- | -- | $19K | -- |
| **Total Current Assets** | $1.55M | $76K | $835K | $695K |
| Property, Plant & Equipment, Net | $1.8K | $2.8K | $96K | $117K |
| Intangible Assets | $14.23M | $15.23M | -- | -- |
| **Total Non-Current Assets** | $14.54M | $15.29M | $215K | $309K |
| **Total Assets** | $16.09M | $15.37M | $1.05M | $1.00M |
| Other Current Liabilities | -- | $373K | -- | -- |
| **Total Current Liabilities** | $891K | $1.43M | $211K | $261K |
| **Total Non-Current Liabilities** | $0 | $0 | $65K | $129K |
| **Total Liabilities** | $891K | $1.43M | $276K | $389K |
| **Total Debt (incl. Leases)** | $308K | $65K | $129K | $185K |
| Common Stock | $1.6K | $325 | $148 | $1.3K |
| Retained Earnings | -$40.65M | -$20.00M | -$11.23M | -$2.02M |
| Accumulated Other Comp. Income | -$2.8K | -$9.8K | -- | -- |
| **Total Stockholders' Equity** | $15.20M | $13.95M | $775K | $614K |
| Total Equity | $15.20M | $13.95M | $775K | $614K |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $659K | $229K | $175K | $1.49M | $481K | $101K | $76K | $59K |
| **Cash & Short-Term Investments** | $659K | $229K | $175K | $1.49M | $481K | $101K | $76K | $59K |
| **Total Current Assets** | $1.49M | $246K | $212K | $1.55M | $598K | $118K | $177K | $76K |
| Property, Plant & Equipment, Net | $1.0K | $1.3K | $1.5K | $1.8K | $2.0K | $2.3K | $2.6K | $2.8K |
| Intangible Assets | $13.35M | $13.65M | $13.94M | $14.23M | $15.92M | $20.69M | $21.53M | $15.23M |
| **Total Non-Current Assets** | $13.62M | $13.93M | $14.24M | $14.54M | $15.93M | $20.72M | $21.58M | $15.29M |
| **Total Assets** | $15.11M | $14.17M | $14.45M | $16.09M | $16.53M | $20.84M | $21.75M | $15.37M |
| Other Current Liabilities | -- | -- | -- | -- | -- | -- | -- | $373K |
| **Total Current Liabilities** | $1.16M | $1.40M | $738K | $891K | $804K | $1.60M | $1.50M | $1.43M |
| **Total Non-Current Liabilities** | $251K | $251K | $237K | $0 | $0 | $0 | $0 | $0 |
| **Total Liabilities** | $1.41M | $1.65M | $975K | $891K | $804K | $1.60M | $1.50M | $1.43M |
| **Total Debt (incl. Leases)** | $266K | $279K | $294K | $308K | $294K | $30K | $48K | $65K |
| Common Stock | $2.2K | $1.8K | $1.7K | $1.6K | $1.4K | $1.1K | $715 | $325 |
| Retained Earnings | -$48.92M | -$45.36M | -$44.05M | -$40.65M | -$37.88M | -$31.65M | -$25.94M | -$20.00M |
| Accumulated Other Comp. Income | -$3.6K | -$5.2K | -$3.2K | -$2.8K | -$2.1K | -$2.0K | -$2.2K | -$9.8K |
| **Total Stockholders' Equity** | $11.08M | $12.53M | $13.48M | $15.20M | $15.73M | $19.24M | $20.25M | $13.95M |
| Total Equity | $13.69M | $12.52M | $13.47M | $15.20M | $15.73M | $19.24M | $20.25M | $13.95M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| Net Income | -$20.64M | -$8.71M | -$9.21M | -$2.00M |
| Depreciation & Amortization | $1.12M | $9.9K | $25K | $3.9K |
| Stock-Based Compensation | $1.17M | $249K | $624K | $234K |
| Change in Inventory | -- | -- | -$19K | -- |
| **Operating Cash Flow** | -$5.85M | -$4.86M | -$7.00M | -$1.35M |
| Capital Expenditure | -- | -- | -$3.5K | -$43K |
| **Free Cash Flow** | -- | -- | -$7.00M | -$1.39M |
| **Investing Cash Flow** | -- | $65K | -$3.5K | -$43K |
| Common Stock Issued | $4.63M | $1.33M | $6.20M | $2.00M |
| **Financing Cash Flow** | $7.27M | $4.13M | $7.06M | $2.05M |
| **Net Change in Cash** | $1.42M | -$671K | $56K | $660K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$3.55M | -$1.31M | -$3.40M | -$2.77M | -$7.62M | -$5.42M | -$4.84M | -$1.95M |
| Depreciation & Amortization | $283K | $280K | $277K | $283K | $256 | $252 | $250 | $255 |
| Stock-Based Compensation | $1.05M | $12K | $1.09M | -$33K | $1.10M | $51K | $51K | $51K |
| **Operating Cash Flow** | -$1.15M | -$261K | -$1.31M | -$1.08M | -$1.24M | -$1.26M | -$2.27M | -$1.13M |
| Common Stock Issued | -- | -- | -- | $2.21M | $1.32M | $431K | $655K | $760K |
| **Financing Cash Flow** | -- | -- | -- | $2.08M | $1.62M | $1.28M | $2.29M | $1.12M |
| **Net Change in Cash** | $427K | $56K | -$1.31M | $1.01M | $380K | $24K | $10K | -$7.1K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| **Gross Margin** | 54.9% | 61.7% | 59.0% | 54.3% |
| **Operating Margin** | -3954.3% | -1294.4% | -1260.3% | -22279.7% |
| **Net Profit Margin** | -4526.8% | -1413.6% | -1259.4% | -22352.1% |
| Return on Equity (ROE) | -135.8% | -62.4% | -1189.1% | -325.4% |
| Return on Assets (ROA) | -128.3% | -56.6% | -876.7% | -199.2% |
| Current Ratio | 1.74x | 0.05x | 3.96x | 2.67x |
| Quick Ratio | 1.67x | 0.04x | 3.87x | 2.62x |
| Debt to Equity | 0.02x | 0.00x | 0.17x | 0.30x |
| **Revenue Growth (YoY)** | -26.0% | -15.8% | +8083.2% | -- |
| Gross Profit Growth (YoY) | -34.1% | -11.9% | +8796.9% | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 52.9% | 54.4% | 52.4% | 54.9% | 60.6% | 61.0% | 57.6% | 61.7% |
| **Operating Margin** | -2887.5% | -4005.6% | -4067.3% | -4015.7% | -4022.7% | -2573.6% | -1992.0% | -1294.4% |
| **Net Profit Margin** | -3673.7% | -4791.3% | -4632.8% | -4526.8% | -4245.3% | -2752.3% | -2187.1% | -1413.6% |
| Return on Equity (ROE) | -99.6% | -120.6% | -142.5% | -135.8% | -126.0% | -73.8% | -55.2% | -62.4% |
| Return on Assets (ROA) | -73.1% | -106.6% | -132.9% | -128.3% | -119.9% | -68.1% | -51.4% | -56.6% |
| Current Ratio | 1.28x | 0.18x | 0.29x | 1.74x | 0.74x | 0.07x | 0.12x | 0.05x |
| Quick Ratio | 0.57x | 0.16x | 0.24x | 1.67x | 0.60x | 0.06x | 0.05x | 0.04x |
| Debt to Equity | 0.02x | 0.02x | 0.02x | 0.02x | 0.02x | 0.00x | 0.00x | 0.00x |
| **Revenue Growth (YoY)** | -17.5% | -59.1% | -37.9% | -10.3% | -36.8% | +3.0% | -48.9% | -56.9% |
| Gross Profit Growth (YoY) | -24.6% | -50.8% | -53.3% | -40.7% | -38.4% | +28.9% | -57.9% | -43.8% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
